<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04810234</url>
  </required_header>
  <id_info>
    <org_study_id>65751.068.2018</org_study_id>
    <secondary_id>METC183019</secondary_id>
    <nct_id>NCT04810234</nct_id>
  </id_info>
  <brief_title>Neural Correlates of tVNS</brief_title>
  <official_title>Functional Neural Correlates of Transcutaneous Vagal Nerve Stimulation: Effects of Anatomical Site and Waveform Parameters - An Exploratory High Resolution fMRI Study in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wingate Institute of Neurogastroenterology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcutaneous vagal nerve stimulation (tVNS) has been applied to a number of disease areas&#xD;
      including visceral pain, depression, cluster headache and Alzheimer's disease. However, there&#xD;
      is marked heterogeneity in these studies pertaining to i) the anatomical site of stimulation&#xD;
      (neck, inner concha or tragus of ear), and ii) the waveform parameters of the stimulating&#xD;
      impulse. This exploratory cross-sectional study will address these knowledge gaps by&#xD;
      comparative functional neuroimaging of the neural correlates of tVNS with disparate&#xD;
      anatomical sites and electrical waveform characteristics during rest in healthy participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood oxygenation level dependent (BOLD) signal activity in the CAN during tVNS</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during auricular tVNS (parameter set 1)</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during cervical tVNS )(parameter set 1)</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during auricular tVNS (parameter set 2)</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during cervical tVNS (parameter set 2)</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during subliminal auricular tVNS (parameter set 1)</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional connectivity / Network Connectivity of CAN regions during &quot;active tVNS&quot; block [to all 5 points as identified above]</measure>
    <time_frame>During stimulation (difference between stim on - stim off blocks)</time_frame>
    <description>fMRI related outcome measure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">16</enrollment>
  <condition>fMRI</condition>
  <condition>Transcutaneous Vagal Nerve Stimulation (tVNS)</condition>
  <condition>Nucleus of the Solitary Tract (NTS)</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous vagal nerve stimulation (tVNS)</intervention_name>
    <description>Cervical and auricular transcutaneous stimulation of the vagus nerve</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female healthy volunteers aged between 18-40 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Of female sex;&#xD;
&#xD;
          -  Healthy participants (defined as those without a pre-existing medical comorbidity)&#xD;
&#xD;
          -  Age between 18 and 40 years;&#xD;
&#xD;
          -  BMI between 18 and 30 kg/m2;&#xD;
&#xD;
          -  Women on oral contraceptives only&#xD;
&#xD;
          -  All subjects should be right-handed.&#xD;
&#xD;
          -  Inclusion will be determined on the basis of availability. Subjects should be able to&#xD;
             attend for 2 scanning sessions.&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Presence of metallic prostheses, pacemakers, metal clips on blood vessels, metal parts&#xD;
             in the eye, an intrauterine device, metal braces, tattoos and/or other metal objects;&#xD;
&#xD;
          -  History of major head trauma or head/brain surgery;&#xD;
&#xD;
          -  History of claustrophobia;&#xD;
&#xD;
          -  History of severe or chronic cardiovascular, respiratory, urogenital,&#xD;
             gastrointestinal/ hepatic, haematological/immunologic, HEENT (head, ears, eyes, nose,&#xD;
             throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional,&#xD;
             endocrine, neurological/psychiatric diseases, major surgery and/or laboratory&#xD;
             assessments which might limit participation in or completion of the study protocol;&#xD;
&#xD;
          -  Use of regular medication, including vitamin and iron supplementation, except oral&#xD;
             contraceptives, within 14 days prior to start of the study;&#xD;
&#xD;
          -  Pregnancy, lactation, wish to become pregnant;&#xD;
&#xD;
          -  High alcohol consumption (&gt;15 alcoholic units consumed per week);&#xD;
&#xD;
          -  Using drugs of abuse;&#xD;
&#xD;
          -  Administration of investigational drugs or participation in any scientific&#xD;
             intervention study which may interfere with this study (to be decided by the principle&#xD;
             investigator), in the 180 days prior to the study;&#xD;
&#xD;
          -  Participants unable to provide informed consent&#xD;
&#xD;
          -  Participants with any systemic disease or medications that may influence the autonomic&#xD;
             nervous system (e.g. beta-agonists or Parkinson's disease)&#xD;
&#xD;
          -  Current smokers or current use of nicotine in any other way (including E-cigarettes&#xD;
             and patches)&#xD;
&#xD;
          -  History of clinical anxiety or depression, or a hospital anxiety or depression score&#xD;
             &gt;8&#xD;
&#xD;
          -  Participants whom score 8 or more on the HADS-questionnaire at study commencement&#xD;
&#xD;
          -  Patient whom have cardiovascular conduction problems&#xD;
&#xD;
          -  Patient with cochlear implants&#xD;
&#xD;
          -  Not meeting any of the inclusion criteria above&#xD;
&#xD;
          -  Any evidence of structural brain abnormalities examined by anatomical MRI will lead to&#xD;
             exclusion&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females only (in order to limit confounding)</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ad Masclee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abraham Beckers, MD</last_name>
    <phone>+31433881844</phone>
    <email>ab.beckers@maastrichtuniversity.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A.B. Beckers, MD</last_name>
      <phone>0433881844</phone>
      <email>ab.beckers@maastrichtuniversity.nl</email>
    </contact>
    <investigator>
      <last_name>A.A.M. Masclee, Prof. MD. PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>D. Keszthelyi, MD. PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A.B. Beckers, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>D. Ivanov, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>H.I.L. Jacobs, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Mary University of London. Wingate Institute of Neurogastroenterology</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

